期刊文献+

持续性真性低水平人绒毛膜促性腺激素升高6例临床特点 被引量:1

Clinical Characteristics of Six Patients with Persistent Real Low-level Elevation of Human Chorionic Gonadotropin
下载PDF
导出
摘要 目的探讨持续性真性低水平人绒毛膜促性腺激素(human chorionic gonadotropin,h CG)升高患者的临床特点和诊治意义。方法 2011年8月至2015年3月北京协和医院诊断为持续性真性低水平h CG升高患者6例,收集患者临床资料,对疾病特点、诊治过程和随诊情况进行回顾性分析。结果 6例患者中,3例继发于葡萄胎清宫术后,3例继发于侵蚀性葡萄胎化疗后。3例侵蚀性葡萄胎患者的中位总疗程数为8个,均有化疗失败史。6例患者随诊中位时间为24个月,自治疗结束至h CG呈低水平升高的中位时间为5.5个月,低水平h CG升高持续的中位时间为16.5个月。4例患者病情稳定,1例进展为绒毛膜癌,1例自然妊娠分娩后h CG降至正常。结论持续性真性低水平h CG升高的持续时间较长,对化疗不敏感,应密切随诊,不宜治疗。 Objective To investigate the clinical characteristics and significance of diagnosis and treat -ment associated with persistent real low-level elevation of human chorionic gonadotropin ( hCG) .Methods Six patients diagnosed with persistent real low-level hCG elevation at Peking Union Medical College Hospital in the period from August 2011 to March 2015 were collected .Clinical records of the 6 patients were reviewed to retro-spectively analyze clinical features , diagnosis and treatment approaches , and follow-up results.Results Among the 6 patients , 3 were secondary to uterine curettage for hydatidiform moles , and the other 3 had received chemo-therapy for invasive moles , in whom the median chemotherapy cycle number was 8 and all experienced failure of at least one chemotherapy regimen .The median follow-up time was 24 months.The median period between the termination of treatment and the initial low-level hCG elevation was 5.5 months.The median duration of low-level hCG elevation was 16.5 months.Four patients had no evidence of progression , 1 patient progressed to choriocar-cinoma, and 1 presented with the hCG level decreasing to the normal range after spontaneous delivery .Conclu-sion Persistent real low-level hCG elevation may persist for a long time and not respond to chemotherapy .Long-term close monitoring is necessary , but treatment is not recommended .
出处 《协和医学杂志》 2015年第3期212-215,共4页 Medical Journal of Peking Union Medical College Hospital
关键词 人绒毛膜促性腺激素 妊娠滋养细胞疾病 化疗 human chorionic gonadotropin gestational trophoblastic disease chemotherapy
  • 相关文献

参考文献10

  • 1Khanlian SA, Smith HO, Cole LA. Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease [ J]. Am J Obstet Gynecol, 2003, 188 : 1254-1259.
  • 2Kohorn EI. What we know about low-level hCG: definition, classification and management [ J ]. J Reprod Med, 2004, 49 : 433-437.
  • 3Kohorn El. Persistent low-level "real" human chorionic gona- dotropin : a clinical challenge and a therapeutic dilemma [ J]. Gynecol Oncol, 2002, 85: 315-320.
  • 4Cole LA, Khanlian SA. Inappropriate management of women with persistent low hCG results [J ]J Reprod Med, 2004, 49 : 423-432.
  • 5钱学茜,万小云.持续性低水平HCG升高的诊治[J].现代妇产科进展,2011,20(1):3-4. 被引量:4
  • 6Cole LA, Butler SA, Khanlian SA, et al. Gestational tropho-blastic diseases : 2. Hyperglycosylated hCG as a reliable mark- er of active neoplasia [J]. Gynecol Oncol, 2006, 102: 151- 159.
  • 7侯进琳,万希润,杨秀玉.持续性低水平人绒毛膜促性腺激素升高的临床意义[J].中华妇产科杂志,2006,41(11):785-786. 被引量:5
  • 8Cole LA. Hyperglycosylated hCG, a review [ J]. Placenta, 2010, 31: 653-664.
  • 9Hwang D, Hancock BW. Management of persistent, unex- plained, low-level human chorionic gonadotropin elevation: a report of 5 cases [J]. J Reprod Med, 2004, 49: 559-562.
  • 10Boafo-Yirenki M, Everard J, Tidy J, et al. A conservative approach in persistent low-level elevation of serum beta-hu- man chorionic gonadotropin following chemotherapy for gesta- tional trophoblastic neoplasia [ J]. J Reprod Med, 2009, 54: 288-290.

二级参考文献25

  • 1Cole LA, Sutton JM, Higgins TN, et al. Between-method variation in HCG test results [ J ]. Clin Chem, 2004,50 : 874-882.
  • 2Cole LA,Sutton JM. Selecting an appropriate HCG test for management of gestational trophoblastic diseases and canc- er cases[ J]. J Reprod Med,2006,51:217.
  • 3Rotmensch-S,Cole LA. False diagnosis and needless ther- apy of presumed malignant disease in women with false- positive human chorionic gonadotropin concentrations[ J ]. Lancet, 2000,355 : 712 -715.
  • 4Cole LA, Builer SA. False positive or phantom HCG re- sult : a serious problem[ J ]. Clin Lab Int ,2001,25:9-14.
  • 5Olsen TG, Hubert PR, Nycum LR. Falsely 'elevated human chorionic gonadotropin leading to unnecessary therapy [ J ]. Obstet Gynecol,2001,98 : 843-845.
  • 6Cole LA, Khanlian SA. Easy fix for clinical laboratories for the false positive defect with the Abbott AxSym total β- HCG test [ J ]. Clin Biochem, 2004,37 : 344-349.
  • 7Cole LA. Phantom HCG and phantom choriocarcinoma [ J]. Gyneeol Oneol, 1998,71:325-329.
  • 8Khanlian SA, Smith HO, Cole LA. Persistent low levels of HCG: a pre-malignant gestational trophoblastie disease [ J]. Am J Obstet Gynecol,2003,188 : 1254-1259.
  • 9Cole LA,Sutton JM. HCG tests in the management of ges- rational trophoblastic diseases [ J ]. Clin Obstet Gynecol, 2003,46:533-540.
  • 10Cole LA, Khanlian SA, Muller CW. Detection of HCG pe- ri-or post-menopause an unnecessary source of alarm [ J]. Am J Obstet Gyneco1,2008 ,198 :275-279.

共引文献7

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部